NCT04749784

Effects of Arterin Cholesterol for Reduction of Lipid Levels

Double-blind, Randomised, Placebo-controlled Study to Evaluate the Benefit and Tolerability of Arterin Cholesterol for Reduction of Lipid Levels

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 114 (estimated)
• Sponsor: Perrigo CSCI · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The main objective of this double-blind, randomised, placebo-controlled study is to assess the benefit and tolerability of Arterin Cholesterol in subjects with elevated lipid levels within a 12-week period of use.

Conditions

• Blood Cholesterol Lowers
• LDL-C

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	High Dose Arterin Cholesterol	240mg active ingredient daily
DIETARY_SUPPLEMENT	Low Dose Arterin Cholesterol	120mg active ingredient daily
DIETARY_SUPPLEMENT	Placebo	Placebo tablet

Timeline

• Start date: 2020-10-30
• Primary completion: 2021-06-01
• Completion: 2021-06-01
• First posted: 2021-02-11
• Last updated: 2021-02-11

Locations

1 site across 1 country: Germany